INTRODUCTION
Tuberculosis (TB) is an ancient disease that was recognized even in prehistoric time. It is presently important worldwide in terms of morbidity, mortality and economic impact. It was declared a global health emergency in 1991(WHO).
EPIDEMIOLOGY
About 30% of the world's population is infected by the organism that causes tuberculosis. 8 to 10 million people develop the disease annually = 1000 new cases every hour. Of these, 11% occur in children <15yrs. Of the childhood cases, 75% occur annually in 22 high burden country that together account for 80% of the world's incidence.
About 2 million deaths occur annually which is equivalent to 52000 deaths weekly. Nigeria has the 5 th largest TB burden worldwide. The FMOH declared TB a national emergency in April 2006. The world is presently witnessing resurgence in the incidence of TB. This may be attributable to worsening economic situation, multidrug resistance, the HIV pandemic, decline of national tuberculosis control programmes and large number of displaced persons living in poor conditions as a result of conflicts and wars.
TB occurs at any age with the highest burden of disease found amongst children less than 4 years of age. Mode of spread is mainly by 1) inhalation-commonest; 2) ingestionthrough infected dairy products (this is rare) and 3) penetration of skin and mucous membranes (very rare). Children are infected from adult index cases with smear positive adults being 10 times more infective than smear negative cases.
Manifestation of TB in children can be predicted based on the Walgreen Timetable highlighted below: Pulmonary tuberculosis -within a few months of primary infection. Miliary and meningeal tuberculosis -2-6 months. TB adenitis -3-9 months. Bones and joints -several years.
Renal and genital tuberculosismay take over a decade.
Pulmonary lesions occurring as a result of reactivation of a dormant focus previously established in the body takes a number of years after primary infection. Treatment regimen consists of at least 4 drugs including an injectable and a fluoroquinolone in the initial phase and at least 3 of the most active and best tolerated drugs in the continuation phase.
PULMONARY TUBERCULOSIS
Initial phase lasts for at least 6 months while the continuation phase lasts for 12-18months. DOTS PLUS is a veritable tool employed by WHO in combating MDR TB.
TB AND HIV/AIDS
Children who acquire HIV by MTCT are also likely to be exposed to TB.
HIV Infection increase the severity of TB in children, morbidity is more prolonged, mortality is higher and treatment may take longer to be effective.
In UCH, 61% of HIV infected children are co infected with TB. They had more rapid disease progression and a higher rate of drug resistance. HIV/TB co infection is the leading cause of AIDS related deaths worldwide.
Managing a child with HIV/TB co infection can be perplexing. This is because history and examination findings are usually alike. The laboratory investigations are mostly non specific and unhelpful. Currently recommended drug therapy for both TB and HIV need modification in patients who are co infected.
-Stavudine /INH-risk of peripheral neuropathy -Rifampicin/nevirapine/efavirenz used in children >3years -Thiacetazone avoided because of fatal steven Johnson syndrome -use of 3 NRTI occasionally, especially in children <3years.
Challenges of therapy include immune reconstitution inflammatory syndrome (IRIS), pill burden, poor adherence, treatment failure, drug toxicity, interaction and resistance. 
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CONCLUSION
Tuberculosis is presently a common infectious disease. It is of major public health significance.
It is presently a global health emergency. Tuberculosis is completely treatable even in the presence of HIV infection. DOTS when properly implemented represents the best and most effective strategy to curb this deadly disease.
Novel drugs and immunomodulation stategies may be important adjuncts to treatment in the future.
